Literature DB >> 11320393

Molecular markers of the risk of oral cancer.

S M Lippman, W K Hong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320393     DOI: 10.1056/NEJM200104263441710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

1.  Kindlin-2-mediated upregulation of ZEB2 facilitates migration and invasion of oral squamous cell carcinoma in a miR-200b-dependent manner.

Authors:  Wenhao Ren; Ling Gao; Cui Qiang; Shaoming Li; Jingjing Zheng; Qibo Wang; Yuan Zhi; Guangfeng Cai; Xinjuan Kong; Minzhan Zhou; Zhigang Qu; Keqian Zhi
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma.

Authors:  Ying Qiu; Zhu-Ling Wang; Shu-Qing Jin; Yu-Fei Pu; Satoru Toyosawa; Katsuyuki Aozasa; Eiichi Morii
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

3.  Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.

Authors:  Kelsey J Rosbach; Michelle D Williams; Ann M Gillenwater; Rebecca R Richards-Kortum
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

4.  Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.

Authors:  Martial Guillaud; Lewei Zhang; Catherine Poh; Miriam P Rosin; Calum MacAulay
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

5.  Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Authors:  Dong M Shin; Hongzheng Zhang; Nabil F Saba; Amy Y Chen; Sreenivas Nannapaneni; A R M Ruhul Amin; Susan Müller; Melinda Lewis; Gabriel Sica; Scott Kono; Johann C Brandes; William J Grist; Rachel Moreno-Williams; Jonathan J Beitler; Sufi M Thomas; Zhengjia Chen; Hyung Ju C Shin; Jennifer R Grandis; Fadlo R Khuri; Zhuo Georgia Chen
Journal:  Clin Cancer Res       Date:  2013-02-19       Impact factor: 12.531

6.  Salivary proteomics for oral cancer biomarker discovery.

Authors:  Shen Hu; Martha Arellano; Pinmanee Boontheung; Jianghua Wang; Hui Zhou; Jiang Jiang; David Elashoff; Roger Wei; Joseph A Loo; David T Wong
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Nobuhiro Ueda; Kazuhiko Yamamoto; Ujjal K Bhawal; Miyako Kurihara; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Clin Exp Metastasis       Date:  2012-08-12       Impact factor: 5.150

8.  Epithelial cell proliferative activity and oral cancer progression.

Authors:  P J Thomson; J V Soames; C Booth; J A O'Shea
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

9.  Podoplanin in the development and progression of oral cavity cancer: a preliminary study.

Authors:  F N Bartuli; F Luciani; F Caddeo; S Compagni; P Piva; L Ottria; C Arcuri
Journal:  Oral Implantol (Rome)       Date:  2012-11-16

10.  Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.

Authors:  Lewei Zhang; Catherine F Poh; Michele Williams; Denise M Laronde; Ken Berean; Pamela J Gardner; Huijun Jiang; Lang Wu; J Jack Lee; Miriam P Rosin
Journal:  Cancer Prev Res (Phila)       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.